World's Best Scientists 2026 revealed!
Pierre I. Karakiewicz

Pierre I. Karakiewicz

Award Badge
Medicine
Canada
2023

D-Index & Metrics

Medicine

D-Index
137
Citations
73900
World Ranking
1904
National Ranking
69

Pierre I. Karakiewicz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pierre I. Karakiewicz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 2,357 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pierre I. Karakiewicz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre I. Karakiewicz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 137 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Canada Leader Award

Overview

Pierre I. Karakiewicz is affiliated with the University of Montreal in Canada. Their research focuses primarily on medicine, with an emphasis on oncology. Their scholarly output includes contributions across several medical subfields such as oncology, pulmonary and respiratory medicine, molecular biology, epidemiology, and cancer research.

The scientist's published work covers key topics within cancer biology and treatment, including:

  • Cutaneous Melanoma Detection and Management
  • Melanoma and MAPK Pathways
  • Renal cell carcinoma treatment
  • Cancer Immunotherapy and Biomarkers
  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • CAR-T cell therapy research

Their recent papers illustrate engagement with diverse aspects of cancer research and therapeutics:

  • "Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program", 2022, published in ESMO Open
  • "Current Trends in Mucosal Melanomas: An Overview", 2023, published in Cancers
  • "Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study", 2020, published in Cytokine
  • "Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial", 2021, published in European Journal of Cancer
  • "Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)", 2021, published in Targeted Oncology

Their publications frequently appear in journals including ESMO Open, Cancers, Cytokine, European Journal of Cancer, and Targeted Oncology, reflecting a focus on clinical cancer treatment and translational research.

Collaboration has been an important aspect of their research. Frequent co-authors include:

  • Luca Galli
  • Ugo De Giorgi
  • Sebastiano Buti
  • Marco Maruzzo
  • Camillo Porta

Best Publications

  • Epidemiology and risk factors of urothelial bladder cancer

    Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman

  • Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

    Shahrokh F. Shariat;Pierre I. Karakiewicz;Ganesh S. Palapattu;Yair Lotan

  • Distribution of metastatic sites in renal cell carcinoma: a population-based analysis

    M. Bianchi;M. Sun;C. Jeldres;S. F. Shariat

  • Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores

    Alberto Briganti;Alessandro Larcher;Firas Abdollah;Umberto Capitanio

  • Multi-institutional validation of a new renal cancer-specific survival nomogram.

    Pierre I. Karakiewicz;Alberto Briganti;Felix K H Chun;Quoc Dien Trinh

  • Distribution of metastatic sites in patients with prostate cancer: A population-based analysis

    Giorgio Gandaglia;Giorgio Gandaglia;Firas Abdollah;Firas Abdollah;Jonas Schiffmann;Vincent Trudeau

  • A PREOPERATIVE NOMOGRAM IDENTIFYING DECREASED RISK OF POSITIVE PELVIC LYMPH NODES IN PATIENTS WITH PROSTATE CANCER

    Ilias Cagiannos;Pierre Karakiewicz;James A. Eastham;Makato Ohori

  • Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate Cancer

    Alberto Briganti;Felix K.-H. Chun;Andrea Salonia;Nazareno Suardi

  • Perioperative Outcomes of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy: Results From the Nationwide Inpatient Sample

    Quoc Dien Trinh;Quoc Dien Trinh;Jesse Sammon;Maxine Sun;Praful Ravi

  • Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients

    Pierre I. Karakiewicz;James A. Eastham;James A. Eastham;Markus Graefen;Markus Graefen;Ilias Cagiannos

  • Radical versus partial nephrectomy: effect on overall and noncancer mortality.

    Laurent Zini;Paul Perrotte;Umberto Capitanio;Claudio Jeldres

  • Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy

    Shahrokh F. Shariat;Ganesh S. Palapattu;Pierre I. Karakiewicz;Craig G. Rogers

  • The effect of age and gender on bladder cancer: a critical review of the literature.

    Shahrokh F. Shariat;John P. Sfakianos;John P. Sfakianos;Michael J. Droller;Pierre I. Karakiewicz

  • Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review

    Maxine Sun;Shahrokh F. Shariat;Christopher Cheng;Vincenzo Ficarra

  • An updated catalog of prostate cancer predictive tools.

    Shahrokh F. Shariat;Pierre I. Karakiewicz;Claus G. Roehrborn;Michael W. Kattan

  • Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins

    David A. Green;Michael Rink;Evanguelos Xylinas;Surena F. Matin

  • Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis

    Maxine Sun;Rodolphe Thuret;Rodolphe Thuret;Firas Abdollah;Firas Abdollah;Giovanni Lughezzani;Giovanni Lughezzani

  • Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.

    Shahrokh F. Shariat;Pierre I. Karakiewicz;Nazareno Suardi;Michael W. Kattan

  • Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer

    Firas Abdollah;R. Jeffrey Karnes;Nazareno Suardi;Cesare Cozzarini

  • Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

    Karim Bensalah;Allan J. Pantuck;Nathalie Rioux-Leclercq;Rodolphe Thuret

Frequent Co-Authors

Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Maxine Sun
Maxine Sun Harvard Medical School
Markus Graefen
Markus Graefen Universität Hamburg
Paul Perrotte
Paul Perrotte University of Montreal
Quoc-Dien Trinh
Quoc-Dien Trinh Brigham and Women's Hospital
Fred Saad
Fred Saad University of Montreal
Felix K.-H. Chun
Felix K.-H. Chun Universität Hamburg
Yair Lotan
Yair Lotan The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or supplementary career pathways in healthcare is a smart move for those interested in medicine. Online education has made it easier than ever to get started in the field or specialize further. For anyone eager to enter the workforce quickly, accelerated lpn programs allow you to complete your practical nurse training faster, helping you begin your nursing career in less time.

For nurses looking to advance, online psych np programs offer a flexible route to becoming a specialized nurse practitioner in mental health. These programs prepare you for leadership roles in psychiatric care and focus on accessible, quality education.

Beyond direct patient care, those interested in managing health services should consider a health care administration online degree. This pathway opens doors to managerial roles and strong job growth in hospitals or clinics.

Graduate-level students seeking advancement in healthcare management can benefit from affordable online mha programs. These programs balance cost and quality, allowing professionals to gain expert knowledge that drives healthcare innovation and efficiency.

Best Scientists Citing Pierre I. Karakiewicz

Trending Scientists

Recently Published Articles